APOE and myocardial infarction: In addition, a –219 (G>T) polymorphism in the APOE promoter has in vitro been shown to decrease transcriptional activity of APOE[24] and has been reported to associate with severity of coronary artery disease [25] and increased risk for myocardial infarction [26].